Hepatitis C, HCV genotypes and hepatic siderosis in patients with chronic renal failure on haemodialysis in Brazil

Nephrology Dialysis Transplantation

Volumn 22, Issue 7, 2007, Pages 2027-2031

  de Paula Farah, Kátia ^a   Carmo, Ricardo Andrade ^a   de Figueiredo Antunes, Carlos Maurício ^a   Serufo, José Carlos ^a   Nobre Jénior, Vandack Alencar ^a   Fonseca de Castro, Lúcia Porto ^a   Leite, Virgínia Hora Rios ^a   Silva, Rogério Augusto Pinto ^a   Álvares, Maria Carolina Barbosa ^a   Corrêa, Guilherme Oliveira ^b   Busek, Solange Cristina Uber ^b   Lambertucci, José Roberto ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Chronic renal failure; Genotyping; Haemodialysis; Hepatitis C; Liver biopsy; Siderosis

Indexed keywords

IRON; VIRUS ANTIBODY; VIRUS RNA;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; BLOOD DONOR; BRAZIL; CHRONIC KIDNEY FAILURE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ECHOGRAPHY; FEMALE; GENOTYPE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY TEST; LIVER BIOPSY; LIVER FIBROSIS; LIVER HEMOSIDEROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

ADULT; BIOPSY; BLOOD DONORS; BRAZIL; COHORT STUDIES; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; KIDNEY FAILURE, CHRONIC; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; MALE; MIDDLE AGED; RENAL DIALYSIS; SIDEROSIS;

EID: 34547851684     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm028     Document Type: Article

References (19)

1. Memon MI, Memon MA. Hepatitis C: An epidemiological review. J Viral Hepatitis 2002; 9: 84-100
2. Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology 2002; 36: 3-10
3. Kalantar-Zadeh K, McAllister CJ, Miller LG. Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: A population based study. Nephrol Dial Transplant 2005; 20: 1662-1669
4. Hu KQ, Lee SM, Hu SX et al. Clinical presentation of chronic hepatitis C in patients with end-stage renal disease and on hemodialysis versus those with normal renal function. Am J Gastroenterol 2005; 100: 2010-2018
5. Fabrizi F, Lunghi G, Finazzi S et al. Decreased serum aminotransferase activity in patients with chronic renal failure: Impact on the detection of viral hepatitis. Am J Kidney Dis 2001; 38: 1009-1015
6. Sterling RK, Sanyal AJ, Luketic VA et al. Chronic hepatitis C infection in patients with end stage renal disease: Characterization of liver histology and viral load in patients awaiting renal transplantation. Am J Gastroenterol 1999; 94: 3576-3582
7. Chan SW, McOmish F, Holmes EC et al. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 1992; 73: 1131-1141
8. Searle J, Kerr JFR, Halliday JW, Powel LW. Pathology of the Liver. Churchill Livingstone, New York: 2002
9. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24: 289-293
10. Fabrizi F, Lunghi G, Guarnori I et al. Hepatitis C virus genotypes in chronic dialysis patients. Nephrol Dial Transplant 1996; 11: 679-683
11. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle JH. Hepatitis C and renal disease: An update. Am J Kidney Dis 2003; 42: 631-657
12. Badalamenti S, Catania A, Lunghi G et al. Changes in viremia and circulation interferon-α during hemodialysis in hepatitis C virus-positive patients: Only coincidental phenomena? Am J Kidney Dis 2003; 42: 143-150
13. Furusyo N, Hayashi J, Kanamoto-Tanaka Y et al. Liver damage in hemodialysis patients with hepatitis C virus viremia: A prospective 10-year study. Dig Dis Sci 2000; 45: 2211-2218
14. Espinosa M, Martin-Malo A, Alvarez de Lara MA, Soriano S, Aljama P. High ALT levels predict viremia in anti-HCV positive HD patients if a modified normal range of ALT is applied. Clin Nephrol 2000; 54: 151-156
15. Fishbane S, Kalantar-Zadeh K, Nissenson AR. Serum ferritin in chronic kidney disease: Reconsidering the upper limit for iron treatment. Semin Dial 2004; 17: 336-341
16. Rabelink TJ, Zwaginga JJ, Koomans HA, Sixma JJ. Trombosis and hemostasis in renal disease. Kidney Int 1994; 46: 287-296
17. Albuquerque W, Arantes V, de Paula Farah K, Lambertucci JR. Acute pancreatitis and acute cholecystitis caused by hemobilia after percutaneous ultrasound-guided liver biopsy. Endoscopy 2005; 37: 1159-1160
18. Afdhal N, Nunes D. Evaluation of liver fibrosis: A concise review. Am J Gastroenterol 2004; 99: 1160-1174
19. Dusheiko GM. The natural history of chronic hepatitis C: Implications for clinical practice. J Viral Hepatitis 1998; 5: 9-12